
    
      Burn patients being followed and treated in the Outpatient Burn Clinic with large areas of
      HTS are approached to participate in the study. Patients who agree to participate and who
      have signed an informed consent are entered into the trial.

      Pre-treatment evaluation and monthly examinations include:

        -  standardized photographs of scar

        -  scar volume

        -  Vancouver Burn Scar Assessment (VBSA)

        -  blood work (TGF-beta, histamine)

        -  urine collection (histamine)

        -  6mm punch biopsy of HTS and adjacent normal skin (every two months)

      Patients are randomized to received with placebo or Intron A 1x106 IU a day for 7 days, then
      3x106 IU 3 SC, three times a week for 23 weeks.
    
  